RELMADA THERAPEUTICS, INC. - Common Stock ($.001 par value) (RLMD)
CUSIP: 75955J402
Q1 2020 13F Holders as of 31 Mar 2020
- Type / Class
- Equity / Common Stock ($.001 par value)
- Shares outstanding
- 74,702,121
- Total 13F shares
- 9,357,083
- Share change
- +2,819,527
- Total reported value
- $319,169,853
- Price per share
- $34.11
- Number of holders
- 43
- Value change
- +$94,707,648
- Number of buys
- 26
- Number of sells
- 15
Quarterly Holders Quick Answers
What is CUSIP 75955J402?
CUSIP 75955J402 identifies RLMD - RELMADA THERAPEUTICS, INC. - Common Stock ($.001 par value) in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Related Filing Research
- Latest 13F filings for newly reported positions.
- Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
- Latest 10-Q/10-K reports for financial context tied to this issuer.
- Recent insider transactions for executive and insider activity.
- SEC investors directory and top value investors for manager drilldown.
- Back to full security ownership history.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 75955J402:
Top shareholders of RLMD - RELMADA THERAPEUTICS, INC. - Common Stock ($.001 par value) (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| TANG CAPITAL MANAGEMENT LLC |
13F
|
Company |
1.7%
|
1,300,000
|
$50,700,000 | — | 31 Dec 2019 | |
| VHCP Management III, LLC |
13F
|
Company |
1%
|
767,938
|
$29,950,000 | — | 31 Dec 2019 | |
| RA CAPITAL MANAGEMENT, L.P. |
13F
|
Company |
1%
|
761,666
|
$29,705,000 | — | 31 Dec 2019 | |
| RTW INVESTMENTS, LP |
13F
|
Company |
0.89%
|
664,484
|
$25,915,000 | — | 31 Dec 2019 | |
| VANGUARD GROUP INC |
13F
|
Company |
0.76%
|
569,753
|
$22,220,000 | — | 31 Dec 2019 | |
| PARSONS CAPITAL MANAGEMENT INC/RI |
13F
|
Company |
0.49%
|
366,933
|
$14,310,000 | — | 31 Dec 2019 | |
| Boxer Capital, LLC |
13F
|
Company |
0.4%
|
300,000
|
$11,700,000 | — | 31 Dec 2019 | |
| TIEDEMANN ADVISORS, LLC |
13F
|
Company |
0.38%
|
282,592
|
$11,021,000 | — | 31 Dec 2019 | |
| Invesco Ltd. |
13F
|
Company |
0.36%
|
269,237
|
$10,500,000 | — | 31 Dec 2019 | |
| FRANKLIN RESOURCES INC |
13F
|
Company |
0.3%
|
225,000
|
$8,775,000 | — | 31 Dec 2019 | |
| Broadfin Capital, LLC |
13F
|
Company |
0.3%
|
220,724
|
$8,608,000 | — | 31 Dec 2019 | |
| BlackRock Finance, Inc. |
13F
|
Company |
0.19%
|
143,113
|
$5,582,000 | — | 31 Dec 2019 | |
| Point72 Asset Management, L.P. |
13F
|
Company |
0.18%
|
136,900
|
$5,339,000 | — | 31 Dec 2019 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
0.17%
|
129,461
|
$5,049,000 | — | 31 Dec 2019 | |
| VHCP Management II, LLC |
13F
|
Company |
0.15%
|
114,876
|
$4,480,000 | — | 31 Dec 2019 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.14%
|
102,614
|
$4,002,000 | — | 31 Dec 2019 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.13%
|
97,108
|
$3,787,000 | — | 31 Dec 2019 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.11%
|
80,166
|
$3,126,000 | — | 31 Dec 2019 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.07%
|
49,187
|
$1,919,000 | — | 31 Dec 2019 | |
| MEYER HANDELMAN CO |
13F
|
Company |
0.04%
|
30,378
|
$1,185,000 | — | 31 Dec 2019 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.03%
|
24,281
|
$947,000 | — | 31 Dec 2019 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.03%
|
23,201
|
$905,000 | — | 31 Dec 2019 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
0.02%
|
17,599
|
$686,000 | — | 31 Dec 2019 | |
| Weiss Multi-Strategy Advisers LLC |
13F
|
Company |
0.02%
|
13,000
|
$507,000 | — | 31 Dec 2019 | |
| World Investment Advisors |
13F
|
Company |
0.02%
|
13,000
|
$507,000 | — | 31 Dec 2019 | |
| ExodusPoint Capital Management, LP |
13F
|
Company |
0.02%
|
11,755
|
$458,000 | — | 31 Dec 2019 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0.01%
|
10,159
|
$396,000 | — | 31 Dec 2019 | |
| Avidity Partners Management LP |
13F
|
Company |
0.01%
|
10,000
|
$390,000 | — | 31 Dec 2019 | |
| Squarepoint Ops LLC |
13F
|
Company |
0.01%
|
8,918
|
$348,000 | — | 31 Dec 2019 | |
| CHARTWELL INVESTMENT PARTNERS, LLC |
13F
|
Company |
0.01%
|
8,780
|
$342,000 | — | 31 Dec 2019 | |
| MYDA Advisors LLC |
13F
|
Company |
0.01%
|
7,000
|
$273,000 | — | 31 Dec 2019 | |
| MORGAN STANLEY |
13F
|
Company |
0.01%
|
6,748
|
$263,000 | — | 31 Dec 2019 | |
| TD ASSET MANAGEMENT INC |
13F
|
Company |
0.01%
|
6,493
|
$253,000 | — | 31 Dec 2019 | |
| BROWN BROTHERS HARRIMAN & CO |
13F
|
Company |
0.01%
|
6,000
|
$234,000 | — | 31 Dec 2019 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.01%
|
5,413
|
$211,000 | — | 31 Dec 2019 | |
| UBS Group AG |
13F
|
Company |
0.01%
|
4,257
|
$166,000 | — | 31 Dec 2019 | |
| Tortoise Investment Management, LLC |
13F
|
Company |
0%
|
2,900
|
$113,000 | — | 31 Dec 2019 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
0%
|
2,143
|
$84,000 | — | 31 Dec 2019 | |
| SIMPLEX TRADING, LLC |
13F
|
Company |
0%
|
2,140
|
$83,000 | — | 31 Dec 2019 | |
| CITIGROUP INC |
13F
|
Company |
0%
|
936
|
$37,000 | — | 31 Dec 2019 | |
| NEXT Financial Group, Inc |
13F
|
Company |
0%
|
306
|
$12,000 | — | 31 Dec 2019 | |
| LADENBURG THALMANN FINANCIAL SERVICES INC. |
13F
|
Company |
0%
|
175
|
$7,000 | — | 31 Dec 2019 | |
| PRELUDE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0%
|
121
|
$5,000 | — | 31 Dec 2019 | |
| ROYAL BANK OF CANADA |
13F
|
Company |
0%
|
36
|
$1,000 | — | 31 Dec 2019 | |
| Glen Eagle Advisors, LLC |
13F
|
Company |
0%
|
25
|
$975 | — | 31 Dec 2019 |
Institutional Holders of RELMADA THERAPEUTICS, INC. - Common Stock ($.001 par value) (RLMD) as of Q1 2020
As of 31 Mar 2020,
RELMADA THERAPEUTICS, INC. - Common Stock ($.001 par value) (RLMD) was held by
43 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
9,357,083 shares.
The largest 10 holders included
RA CAPITAL MANAGEMENT, L.P., TANG CAPITAL MANAGEMENT LLC, Avoro Capital Advisors LLC, RTW INVESTMENTS, LP, VR Adviser, LLC, VANGUARD GROUP INC, BlackRock Inc., PARSONS CAPITAL MANAGEMENT INC/RI, CITADEL ADVISORS LLC, and BOXER CAPITAL, LLC.
This page lists
43
institutional shareholders reporting positions in this security
for the Q1 2020 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q1 2020 vs Q4 2019 Across Filers
Q4 2019 holders
44
Q1 2020 holders
43
Holder diff
-1
| Investor | Q4 2019 Shares | Q1 2020 Shares | Share Diff | Share Chg % | Q4 2019 Value $ | Q1 2020 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.